HKN-21720-63512
3 vaccinations
2 coded responses
32 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 967 / HI
- Registered
- 2021-02-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-25
Dose 1 — Pfizer-BioNTech
-
2021-02-27
Registered in v-safe
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-04
- 2021-03-11
- 2021-03-18
-
2021-03-22
Dose 2 — Pfizer-BioNTech
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-06-23
- 2021-09-20
-
2021-12-17
Dose 3 — Pfizer-BioNTech
- 2021-12-17
- 2021-12-19
- 2021-12-23
- 2021-12-24
- 2021-12-31
- 2022-01-07
-
2022-01-14
Survey response — day 28, dose 3MedDRA: Exposure to SARS-CoV-2, Nasopharyngitis — Feeling: FairFree text: Cold like symptoms (Covid exposure 3 days ago)MedDRA releases: 2024-11 · check-in free text available
-
2022-01-21
Survey response — day 35, dose 3MedDRA: Nasal congestion, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Congestion, head and nasalMedDRA releases: 2024-11 · check-in free text available
- 2022-01-30
- 2022-03-18
- 2022-06-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Pfizer-BioNTech | |
| 2 | 2021-03-22 | Pfizer-BioNTech | |
| 3 | 2021-12-17 | Pfizer-BioNTech | No |
Free text
Release 10 — day 28, dose 3
Symptoms: Cold like symptoms (Covid exposure 3 days ago)
Release 11 — day 35, dose 3
Symptoms: Congestion, head and nasal
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release